Back to Archived Journals » Journal of Receptor, Ligand and Channel Research » Volume 7

Structure-based three-dimensional pharmacophores as an alternative to traditional methodologies

Authors Gaurav A, Gautam V

Received 7 January 2014

Accepted for publication 2 April 2014

Published 12 June 2014 Volume 2014:7 Pages 27—38


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 4

Anand Gaurav,1 Vertika Gautam2

1Faculty of Pharmaceutical Sciences, UCSI University, 2Department of Chemistry, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia

Abstract: Structure-based pharmacophore approaches have become widely used in drug discovery and design. This can be attributed to the development of new tools and methods over the past decade. Various tools based on different premises have been developed, including active site information in traditional pharmacophores. These tools have been widely used in virtual screening, de novo design, and lead optimization and been proven to be highly successful. Studies based on simultaneous use of structure-based pharmacophores, ligand-based pharmacophores, and docking have also come into the picture recently. Here, the development of structure-based pharmacophores as an alternative to traditional drug discovery approaches is discussed, with emphasis on the advances and latest developments in tools and success stories involving their application.

Keywords: structure-based pharmacophore, LigandScout, pocket, DS Catalyst SBP, Shape4, docking, virtual screening

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]